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The tumor cell proliferation, migration and invasion were inﬂuenced
by the interaction between the cancer cells and their microenviron-
ment. In current study, we established two pairs of the primary
ﬁbroblast cultures from colorectal adenocarcinoma tissues and the
normal counterparts and identiﬁed 227 proteins in the colonic
ﬁbroblast secretomes; half of these proteins were novel. The mass
spectrometry data and analyzed results presented here provide
novel insights into the molecular characteristics and modulatory role
of colon cancer associated ﬁbroblasts. The data is related to
“Identiﬁcation of colonic ﬁbroblast secretomes reveals secretory
factors regulating colon cancer cell proliferation” by Chen et al. [1].
& 2014 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).vier Inc. This is an open access article under the CC BY license
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More speciﬁc subject area Cancer microenvironment
Type of data Excel tables
How data was acquired Mass spectrometry, data acquired using Synapt G1 mass spectrometer
Data format Analyzed
Experimental factors Conditioned media were collected, proteins were concentrated using ﬁlters
Experimental features The proteins were separated using SDS-PAGE, in-gel tryptic digested and analyzed using LC-MS
Data source location Shanghai, China
Data accessibility The data is available with this article and is related to [1]Value of the data 227 colonic ﬁbroblast secretome proteins are identiﬁed at a false discovery rate of 1.3%.
 125 proteins (55.1%) are novel identiﬁed secretome proteins of colonic ﬁbroblasts.
 These proteins are enriched for functional categories of extracellular matrix, adhesion, cell motion,
inﬂammatory response, redox homeostasis and peptidase inhibitor.
 The data are valuable for understanding of the molecular feature of colonic ﬁbroblasts and are ripe
for further exploration and data mining.
 The data are useful for comparing purpose when addressing the heterogeneities of the ﬁbroblast
expressions from different isolation.1. Data, experimental design, materials and methods
Secreted proteins were extracted from the conditioned medium of one pair of the ﬁbroblast
cultures. We performed a proteomic analysis of the proteins using a Synapt G1 mass spectrometer.
The mass data interpretation was performed using ProteinLynx Global Server, X! Tandem and Scaffold
softwares. The proteomic data presented here include the protein and spectrum identiﬁcation results,
as well as the cellular component annotation and functional analyzing results. 227 proteins were
identiﬁed with a false discovery rate of 1.3% based on 15,000 assigned spectra. Half of the proteins
were novel identiﬁcations in the secretome of colonic ﬁbroblasts comparing with the known report.
The subcellular localization of the identiﬁed proteins were annotated using UniProt database, DAVID,
SignalP, SecretomeP, Phobius, WoLF PSORT and exosome databases. The occurrence of the ﬁbroblast
secretome proteins in the colon cancer cell proteomes was also analyzed. The functional enrichment
of the identiﬁed proteins was performed using DAVID.2. Establishment of ﬁbroblast cultures from fresh surgical specimen
We established two pairs of colon cancer-associated ﬁbroblast (CAF) and normal ﬁbroblast (NF)
cultures. The fresh colorectal cancer tissues and adjacent normal colonic tissues (at least 5 cm away
from the loci of cancerous tissue) from two patients with colon ulcerated adenocarcinoma were
collected during surgery at the Zhongshan Hospital of Fudan University according to the procedure
described in the Journal of Proteomics paper [1]. The clinic and pathological data of the two patients
are available in Supplementary Table 1.3. Proteomic analysis of the colonic CAF and NF secreted proteins (SPs)
Fifty micro gram of the SP extracted from the 1031_NF and 1031_CAF conditioned medium (CM)
were separated using 10% SDS-PAGE. Equal amount of sample was loaded in triplicate. Two gel lanes
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an optimized procedure [2]. The digested peptides were analyzed using Synapt G1 mass spectrometer
as described previously [3]. Brieﬂy, the peptide mixture from each gel slice was ﬁrst loaded onto a
reverse phase (RP) trap column (C18, 5 μm, 180 μm20-mm Symmetry C18 nanoAcquity column,
Waters) for on-line desalting at a ﬂow rate of 10 μL/min. The peptides were then eluted from the trap
column into an analytical fused silica nanoAcquity UPLC column of 75 μm200-mm inner diameter
packed with C18 of 1.7-μm pore diameter stationary phase (Waters). The column oven temperature
was maintained at 40 1C. Mobile phase A contains 0.1% formic acid (FA) in water, while mobile phase B
was 100% acetonitrile (ACN)/0.1% FA. The mobile phases were delivered using a nanoAcquity UPLC
system (Waters) at a ﬂow rate of 250 nL/min. The peptides were separated with a linear gradient of
3–15% mobile phase B (5 min), 15–35% B (65 min), 35–98% B (5 min), 98% B (5 min), and 98–3% B
(10 min). The peptides were ionized at the end of a 10-μm-inner diameter PicoTip nanospray emitter
(New Objective) which was connected to the end of the analytical column. A voltage of 3200 V was
applied to the emitter for a steady spray. The ions got into a Synapt G1 mass spectrometer (Waters) via
a Nano electrospray ionization (ESI) source. The source-inside temperature was maintained at 100 1C.
During the data acquisition, a reference sprayer using 320 fmol/μL lock mass compound [Glu1]-
ﬁbrinopeptide B (GFB) (Sigma) was sampled with a frequency of 30 s at a ﬂow rate of 200 nL/min. The
precision of the mass data was calibrated using the doubly charged monoisotopic ion of GFB. The MSE
data was acquired using alternating low-energy collision at 6 eV for survey scan and high-energy
collision ramped from 15 to 55 eV for tandem MS. The spectral acquisition time in each mode of 1.2 s
and a full cycle was 2.44 s. The mass range of the survey scan was set at m/z 100 to 1800.4. MS data interpretation by database (DB) searching
ProteinLynx Global Server (PLGS) v2.5 (Waters) was used for peak picking and DB searching as
described previously [3]. The searching DB contains 20,273 human protein entries extracted from
UniProtKB/Swiss-Prot Release 2014_01. The DB searching result ﬁles in zip format were exported from
PLGS using a Scaffold plugin and were parsed into Scaffold v4.2.1 (Proteome Software, Inc.). For data
integration and validation by Scaffold, the standard legacy PeptideProphet scoring system [4] and the
standard experiment wide protein grouping method were adopted. An integrated version of X!
Tandem (Version: CYCLONE (2010.12.01.1)) in Scaffold was used for an additional DB searching using
the same parameters as PLGS. The searching results from both PLGS and X! Tandem were combined
automatically by Scaffold. Protein identiﬁcations were accepted with a protein probability 499.0%
assigned by ProteinProphet [5] and Z3 unique peptides of o0.1% false positive rate (FDR) assigned
by PeptideProphet algorithm [4]. The protein abundance was represented by the exclusive spectrum
count which was normalized across different samples. Supplementary Table 2 contains the proteomic
analysis and the bioinformatics analysis results of the identiﬁed proteins. The table lists the protein
name, gene name, gene symbol and molecular weight. The proteomic data include the exclusive
spectrum count, exclusive unique peptide count, percent coverage, exclusive unique spectrum count
and the total spectrum count. These results were output from Scaffold. The subcellular localization
analysis results include the information or prediction from UniProt, SignalP, Phobius, SecretomeP,
WoLF PSORT, DAVID, ExoCarts and Vesiclepedia. Based on these analyses, a ﬁnal annotation was made
manually. Tissue speciﬁcity gene expression enrichment was analyzed using the Gene Enrichment
Proﬁler and a smooth muscle-enriched expression might indicate the characteristics of myoﬁbroblast.
A comparison to the identiﬁcation results of De Boeck et al.'s was made [6]. We also compared the
identiﬁed ﬁbroblast protein with known colon cancer proteins reported by 10 articles. The ﬁrst paper
by Meike et al. analyzed the expressions of colon cancer cell lines Caco-2, HT-29, HCT-116, SW480,
SW1398 and identiﬁed 2361 proteins [7]. The other papers containing colon cancer cell identiﬁcations
are listed in Table 1. The GO analysis results, including the biological process, cellular component and
molecular function, were generated using Scaffold. We downloaded the GO annotation ﬁle for human
gene (ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/HUMAN/gene_association.goa_human.gz) on February 6,
2014 and used this GO ﬁle for annotation using Scaffold.
Table 1
Colon cancer proteomic identiﬁcations used for comparison.
No. Colon cell lines analyzed Protein identiﬁed Reference
1 Caco-2/HT-29/HCT-116/SW480/SW1398 2361 [7]
2 CaCo-2/HCT-GEO 176 [8]
3 SW480/SW620 1929 [9]
4 LIM1215 56 [10]
5 SW480/SW620 910 [11]
6 LIM1215 136 [12]
7 SW620 234 [13]
8 KM12C/KM12SM 2088 [14]
9 Colo205/SW480/SW620 2042 [15]
10 SW480/SW620 1675 [16]
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peptide sequence, PLGS score, X! Tandem score, charge, intensity, etc. The Supplementary Table 3 is an
output from Scaffold using “export” function for spectrum report with minor editing. Statistics on the
spectrum and protein identiﬁcation reported by Scaffold is summarized in Supplementary Table 4. It
should be noted that the “Show lower scoring matches” of Scaffold was disabled when reporting and
exporting the identiﬁcation results.
The spectra of eight representative proteins identiﬁed in the ﬁbroblast secretomes are shown in
Supplementary Fig. 1, together with an illustration of the sequence coverage of each protein across
different proteomic analyses. The spectra and the sequence coverage illustrations were extracted from
the Scaffold results.5. Subcellular localization analysis of the identiﬁed proteins
To get a precise prediction, the subcellular localization analysis was performed using multiple
methods. The cellular component annotations by Gene Ontology (GO) of the identiﬁed proteins were
extracted from the ﬂat text ﬁle retrieved from UniProt DB (hwww.uniprot.org). Similarly, the GO
annotation of the cellular component was analyzed using the DAVID Bioinformatics Resources
(http://david.abcc.ncifcrf.gov/). SignalP v4.1 (http://www.cbs.dtu.dk/services/SignalP/) and Phobius
(http://phobius.sbc.su.se/) were chosen to analyze the classical SP. Proteins longer than 6000 amino
acids were excluded from analysis by SignalP. Non-classical SPs were predicted using SecretomeP v2.0
(http://www.cbs.dtu.dk/services/SecretomeP/), with a length restriction of less than 4000 amino
acids. Additionally, the subcellular localization was predicted using WoLF PSORT (http://wolfpsort.seq.
cbrc.jp/). Potential exosome protein were revealed by comparing the protein names and accessions
with those registered in ExoCarta DB version 4.1 (http://www.exocarta.org) [17] and Vesiclipedia DB
version 2.1 (http://www.microvesicles.org/) [18]. All of these information were integrated in
Supplementary Table 2 and manually checked and a ﬁnal annotation was made for each protein.6. RNA interference (RNAi) and ectopic expression
To address the functionalities of the identiﬁed proteins, we silenced the coding genes of these
proteins in a normal colonic ﬁbroblast cell line, CCD-18Co, and then performed coculture assays with
colon cancer cells. Follistatin-related protein 1 (FSTL1) was chosen for ectopic expression analysis in
CCD-19Co, which was used for coculture assays. The small interference RNAs (siRNAs) and cloning
primers are listed in Supplementary Table 5.
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GO enrichment analysis was performed using DAVID and signiﬁcant enrichment categories were
accepted with p value and Benjamini value less than 0.05. The enrichment analysis results are shown
in Supplementary Table 6. Tissue speciﬁcity gene expression enrichment was analyzed using the Gene
Enrichment Proﬁler (http://xavierlab2.mgh.harvard.edu/EnrichmentProﬁler/). The results for tissue
expression enrichment are embedded in Supplementary Table 2.8. Comparison with the known identiﬁcations of colon cancer cells
The identiﬁed ﬁbroblast proteins were compared with a batch of known proteomic analyses of
colon cancer cells to evaluate their speciﬁc expression properties [7–16]. The identiﬁed proteins of
these reports varied from 40 to 2300. The comparison was mainly based on ofﬁcial gene symbols. In
cases when needed, the International Protein Index (IPI) accessions were mapped to gene symbols
and UniProt accessions using the Protein Identiﬁer Cross-Reference (PICR) (http://www.ebi.ac.uk/
Tools/picr/). The analyzing results were integrated in Supplementary Table 2. Area-proportional Venn
diagram was generated with BioVenn (http://www.cmbi.ru.nl/cdd/biovenn/index.php).Acknowledgments
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